Analyst Derek Archila of Wells Fargo assigned a Hold rating on Apellis Pharmaceuticals (APLS – Research Report), retaining the price ...

Bank of America Securities analyst Tazeen Ahmad has maintained their bullish stance on APLS stock, giving a Buy rating yesterday. Tazeen Ahmad ...

European regulators rejected Apellis Pharmaceuticals' embattled eye drug, Syfovre, and Apellis stock tumbled to a month-low.

Apellis Pharmaceuticals (APLS) is down more than -9% after the European Medicines Agency upheld its negative opinion on the marketing authorization for the company’s Syfovre eye drug. Frontline Plc ...

Apellis Pharmaceuticals (APLS) closed down more than -12% after the European Medicines Agency upheld its negative opinion on the marketing authorization for the company’s Syfovre eye drug. Frontline ...

“We have seen the profound impact this medicine has had for GA patients in the U.S. and remain committed to expanding access to this crucial treatment, focusing on serving unmet patient needs in the U ...

Rayne Beau, a lost cat, managed to travel 800 miles back home after vanishing during a camping trip in Yellowstone National Park. Found exhausted in Roseville, California, he was reunited with his ...

43 years ago today, Sandra Day O'Connor was sworn in as the first female Supreme Court Justice. She was approved in the Senate 99-0, ...

Greece is to battle the housing crisis by further regulating Airbnb and house rentals as of 2025, imposing restrictions on short-term leasing while providing incentives for long-term rentals to owners ...